Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-07

Clinical Trial Update: Mercaptopurine Therapy in Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on mercaptopurine therapy for ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mercaptopurine (Mercaptopurine)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Colitis, Ulcerative | Phase 3 | Status: UNKNOWN